Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.

Date publication

novembre 2022

Journal

The Lancet regional health. Europe

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier , Pr MEYER Nicolas

Tous les auteurs :
Debieuvre D, Molinier O, Falchero L, Locher C, Templement-Grangerat D, Meyer N, Morel H, Duval Y, Asselain B, Letierce A, Trédaniel J, Auliac JB, Bylicki O, Moreau L, Fore M, Corre R, Couraud S, Cortot A, ,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36108315

Résumé

Long-term changes in lung cancer (LC) patients are difficult to evaluate. We report results from the French KBP-2020 real-life cohort.

Mots clés

Adenocarcinoma, CPHG, French College of General Hospital Pulmonologists, Early mortality, Epidemiology, LC, Lung Cancer, Lung cancer, NPH, Nonacademic public hospitals, NSCLC, Non-small-cell lung cancer, Non-small-cell lung cancer, PS, Performance status, Real-life, SCLC, Small-cell lung cancer, Small-cell lung cancer, Smoking habits, TMB, Tumour molecular burden, Tumor characteristics

Référence

Lancet Reg Health Eur. 2022 11;22:100492